Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice S Fujisaka, I Usui, A Bukhari, M Ikutani, T Oya, Y Kanatani, K Tsuneyama, ... Diabetes 58 (11), 2574-2582, 2009 | 849 | 2009 |
IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a … Y Zen, K Harada, M Sasaki, Y Sato, K Tsuneyama, J Haratake, ... The American journal of surgical pathology 28 (9), 1193-1203, 2004 | 662 | 2004 |
Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Küttner's tumor) S Kitagawa, Y Zen, K Harada, M Sasaki, Y Sato, H Minato, K Watanabe, ... The American journal of surgical pathology 29 (6), 783-791, 2005 | 480 | 2005 |
Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma H Zheng, H Takahashi, Y Murai, Z Cui, K Nomoto, H Niwa, K Tsuneyama, ... Anticancer research 26 (5A), 3579-3583, 2006 | 468 | 2006 |
Liver‐targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis RY Lan, C Cheng, ZX Lian, K Tsuneyama, GX Yang, Y Moritoki, ... Hepatology 43 (4), 729-737, 2006 | 368 | 2006 |
Identification of innate IL-5–producing cells and their role in lung eosinophil regulation and antitumor immunity M Ikutani, T Yanagibashi, M Ogasawara, K Tsuneyama, S Yamamoto, ... The Journal of Immunology 188 (2), 703-713, 2012 | 353 | 2012 |
RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low–molecular weight heparin KM Myint, Y Yamamoto, T Doi, I Kato, A Harashima, H Yonekura, ... Diabetes 55 (9), 2510-2522, 2006 | 309 | 2006 |
Hepatic IL-17 responses in human and murine primary biliary cirrhosis RYZ Lan, TL Salunga, K Tsuneyama, ZX Lian, GX Yang, W Hsu, ... Journal of autoimmunity 32 (1), 43-51, 2009 | 292 | 2009 |
IL‐2 receptor α−/− mice and the development of primary biliary cirrhosis K Wakabayashi, ZX Lian, Y Moritoki, RY Lan, K Tsuneyama, YH Chuang, ... Hepatology 44 (5), 1240-1249, 2006 | 268 | 2006 |
Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1α-dependent and HIF-1α-independent manner in obese mice S Fujisaka, I Usui, M Ikutani, A Aminuddin, A Takikawa, K Tsuneyama, ... Diabetologia 56, 1403-1412, 2013 | 254 | 2013 |
Septic shock is associated with receptor for advanced glycation end products ligation of LPS Y Yamamoto, A Harashima, H Saito, K Tsuneyama, S Munesue, ... The Journal of Immunology 186 (5), 3248-3257, 2011 | 247 | 2011 |
IL‐12/Th1 and IL‐23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy CY Yang, X Ma, K Tsuneyama, S Huang, T Takahashi, NP Chalasani, ... Hepatology 59 (5), 1944-1953, 2014 | 236 | 2014 |
Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement Y Nakanuma, Y Zen, K Harada, M Sasaki, A Nonomura, T Uehara, ... Pathology international 60 (3), 167-174, 2010 | 230 | 2010 |
High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer S Hojo, K Koizumi, K Tsuneyama, Y Arita, Z Cui, K Shinohara, T Minami, ... Cancer research 67 (10), 4725-4731, 2007 | 230 | 2007 |
CD206+ M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors A Nawaz, A Aminuddin, T Kado, A Takikawa, S Yamamoto, K Tsuneyama, ... Nature communications 8 (1), 286, 2017 | 223 | 2017 |
Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation H Honda, Y Nagai, T Matsunaga, N Okamoto, Y Watanabe, K Tsuneyama, ... Journal of leukocyte biology 96 (6), 1087-1100, 2014 | 212 | 2014 |
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease K Wakabayashi, ZX Lian, PSC Leung, Y Moritoki, K Tsuneyama, MJ Kurth, ... Hepatology 48 (2), 531-540, 2008 | 207 | 2008 |
Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray H Zheng, H Takahashi, Y Murai, Z Cui, K Nomoto, S Miwa, K Tsuneyama, ... Journal of clinical pathology 60 (3), 273-277, 2007 | 203 | 2007 |
Hepatocellular carcinoma arising in non‐alcoholic steatohepatitis Y Zen, K Katayanagi, K Tsuneyama, K Harada, I Araki, Y Nakanuma Pathology international 51 (2), 127-131, 2001 | 203 | 2001 |
Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice Y Yamazaki, I Usui, Y Kanatani, Y Matsuya, K Tsuneyama, S Fujisaka, ... American Journal of Physiology-Endocrinology and Metabolism 297 (5), E1179-E1186, 2009 | 197 | 2009 |